RGNX Stock Analysis: Buy, Sell, or Hold?
RGNX - REGENXBIO Inc.
$10.48
0.24 (2.34%)
▲
5d:
+34.36%
30d:
+56.65%
90d:
+26.88%
WAIT
LOW Confidence
Analysis Updated: Jun 26, 2026 12:00 AM ET
Earnings: Aug 06, 2026
Get Alerted When RGNX Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
Bottom Line:
⏸️ WAIT FOR BETTER ENTRY: RGNX is 22.0% above its trading range ($8.59). While momentum could continue, risk/reward favors waiting for a pullback.
⏸️ WAIT FOR BETTER ENTRY: RGNX is 22.0% above its trading range ($8.59). While momentum could continue, risk/reward favors waiting for a pullback.
In-depth Analysis How we analyze
Valuation Analysis: RGNX is currently trading at $10.48, which is considered extended relative to its 30-day fair value range of $5.81 to $8.59.
Technical Outlook: Technically, RGNX is in a downtrend. Immediate support is located at $6.32, while resistance sits at $10.98.
Market Sentiment: The stock shows a mixed technical setup (45/100), with neutral trendline and momentum signals. Wall Street analysts see significant upside, with an average price target of $24.36 (+132.5%). Current signals suggest waiting for a better entry point before initiating new positions.
Technical Outlook: Technically, RGNX is in a downtrend. Immediate support is located at $6.32, while resistance sits at $10.98.
Market Sentiment: The stock shows a mixed technical setup (45/100), with neutral trendline and momentum signals. Wall Street analysts see significant upside, with an average price target of $24.36 (+132.5%). Current signals suggest waiting for a better entry point before initiating new positions.
Quick Decision Summary
Current Position
EXTENDED
Historical Trading Range
$5.81 -
$8.59
Company Quality Score
55/100
(HOLD)
Volume Confirmation
HIGH
Confidence Score
40.5%
All Signals
- BEARISH: Price significantly overextended (+22.0% above its trading range)
- NEUTRAL: Mixed technical signals (45/100)
- BULLISH: High volume confirmation
- BULLISH: Trading 132.5% below Wall St target ($24.36)
Trading Range Analysis
30-Day Trading Range
$5.81 -
$8.59
Current vs Trading Range
EXTENDED
Support & Resistance Levels
Support Level
$6.32
Resistance Level
$10.98
Current Trend
Downtrend
Technical data as of
Jun 26, 2026
Fundamental Context
Forward P/E (Next Year Est.)
-4.07
Wall Street Target
$24.36
(+132.5%)
Revenue Growth (YoY)
-92.8%
Share & Embed Analysis
Last updated: June 27, 2026 9:13 AM ET
Data refreshes hourly during market hours. Next update: 10:13 AM
Data refreshes hourly during market hours. Next update: 10:13 AM
🔥 Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is RGNX showing a specific setup today?
Insider Activity (6 Months)
0
Buys
1
Sells
Net
INSIDERS SELLING
Recent Transactions
Steve Pakola
SELL
5124 shares
2026-03-10
Top Rated Biotechnology Stocks
Top-rated stocks in Biotechnology by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
AXSM
Axsome Therapeutics Inc |
STRONG BUY
19 analysts |
$276 | 59 HOLD |
|
RARE
Ultragenyx |
STRONG BUY
20 analysts |
$52 | 57 HOLD |
|
CYTK
Cytokinetics Inc |
STRONG BUY
21 analysts |
$105 | 61 BUY |
|
VKTX
Viking Therapeutics Inc |
STRONG BUY
19 analysts |
$93 | 56 HOLD |
|
CRNX
Crinetics Pharmaceutical… |
STRONG BUY
17 analysts |
$83 | 60 HOLD |
